Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Placebo Trial'

Placebo Trial published presentations and documents on DocSlides.

Pravastatin in Elderly Individuals at Risk of Vascular Dise

Pravastatin in Elderly Individuals at Risk of Vascular Dise

  • min-jolicoeur
  • 5 Slides

Presented at Late Breaking Clinical Trials. AHA 2...

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

Comparison of Adherence among Partners’ PrEP Participants on Placebo before and after Release of

  • briana-ranney
  • 0 Slides

B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Buku...

New Drug Update 2016 A Formulary Approach

New Drug Update 2016 A Formulary Approach

  • test
  • 0 Slides

J. Russell May, Pharm.D., FASHP. Clinical Profess...

Eating Behavior Defect: Consequences and New treatment Modalities

Eating Behavior Defect: Consequences and New treatment Modalities

  • lois-ondreau
  • 0 Slides

Charles SAAB MD / CEHP / MAACE . Consultant Endo...

Medications for Obesity Management

Medications for Obesity Management

  • aaron
  • 0 Slides

Faisal . saeed. , MD.. Advocate weight Management...

Kenneth W. Mahaffey, MD,

Kenneth W. Mahaffey, MD,

  • cheryl-pisano
  • 0 Slides

on behalf of the TRACER Investigators and Committ...

1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery

1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery

  • mitsue-stanley
  • 0 Slides

Dr. PJ Devereaux on behalf of POISE. Investigato...

How Do We Treat Obesity?

How Do We Treat Obesity?

  • liane-varnes
  • 0 Slides

Weight Loss Medications. 2. 3. Phentermine. 4. DE...

Planning for Retirement: Depression

Planning for Retirement: Depression

  • debby-jeon
  • 0 Slides

Richard C. Shelton, M.D.. James G. Blakemore Rese...

How Do We Treat Obesity?

How Do We Treat Obesity?

  • karlyn-bohler
  • 0 Slides

Weight Loss Medications. 2. 3. Phentermine. 4. DE...

Asthma: A Highly Prevalent and Often Inadequately Controlled Disease

Asthma: A Highly Prevalent and Often Inadequately Controlled Disease

  • lois-ondreau
  • 0 Slides

1. Centers for Disease Control and Prevention (CD...

UB Dept of Neurology UBMD Neurology/JNI

UB Dept of Neurology UBMD Neurology/JNI

  • alida-meadow
  • 0 Slides

brains. &GAINS. November 2, 2013. 9-12 a.m.. ...

CV safety & Outcome trials of

CV safety & Outcome trials of

  • aaron
  • 0 Slides

Oral . Antidiabetics. Adverse CV events led the F...

Apixaban vs VKA and

Apixaban vs VKA and

  • cheryl-pisano
  • 23 Slides

Apixaban vs VKA and Aspirin vs Placebo in Patie...

ETHICAL ASPECTS of

ETHICAL ASPECTS of

  • cheryl-pisano
  • 25 Slides

ETHICAL ASPECTS of PLACEBO SURGERY AAOS ETHICS ...

AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSIONS 2019

AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSIONS 2019

  • yoshiko-marsland
  • 30 Slides

AMERICAN COLLEGE OF CARDIOLOGY SCIENTIFIC SESSION...

PPAR  activation Clinical

PPAR  activation Clinical

  • maniakti
  • 18 Slides

evidence. Evolution of clinical evidence supportin...

Best of ASCO GU Session Sandy Srinivas.MD

Best of ASCO GU Session Sandy Srinivas.MD

  • experimentgoogle
  • 59 Slides

Stanford University. Outline. Abstract #4. :. . I...

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving

Long -Term Efficacy of Dapagliflozin in T2DM Patients Receiving

  • vamput
  • 11 Slides

High-Dose Insulin. John . P.H. . Wilding, DM, FRCP...

Edward Fox, MD, PhD Phase 2 Multicenter Study Results of

Edward Fox, MD, PhD Phase 2 Multicenter Study Results of

  • medmacr
  • 17 Slides

Ublituximab. , a Novel Glycoengineered Anti-CD20 M...

Management of Dementia:

Management of Dementia:

  • maniakiali
  • 39 Slides

Pharmacologic and Non-Pharmacologic . Approaches. ...

EDUCATIONAL SLIDE MODULES

EDUCATIONAL SLIDE MODULES

  • dsuser1
  • 81 Slides

Module D: . Evaluating CV safety and potential for...

New Insights from EXSCEL

New Insights from EXSCEL

  • pongre
  • 22 Slides

M. Angelyn Bethel, MD. Associate Professor of Diab...

Submitter Name: Marta Ceko

Submitter Name: Marta Ceko

  • jasmine
  • 1 Slides

PI Name: Tor D. WagerPI email: tor.wager@colorado....

HIGHLIGHTSOFPRESCRIBINGINFORMATIONThesehighlightsdonotincludealltheinf

HIGHLIGHTSOFPRESCRIBINGINFORMATIONThesehighlightsdonotincludealltheinf

  • byrne
  • 13 Slides

Notforthereliefofacutebronchospasmorstatusasthmati...

JAPIVOL 52MARCH 2004wwwjapiorg231

JAPIVOL 52MARCH 2004wwwjapiorg231

  • stella
  • 7 Slides

Update ArticleBiologics in Rheumatoid ArthritisP K...

HIGHLIGHTSOFPRESCRIBINGINFORMATIONThesehighlightsdonotincludealltheinf

HIGHLIGHTSOFPRESCRIBINGINFORMATIONThesehighlightsdonotincludealltheinf

  • sadie
  • 13 Slides

Notforthereliefofacutebronchospasmorstatusasthmati...

According to template WWCLINER102SD02 VERSION N02 05OCT2007Thes

According to template WWCLINER102SD02 VERSION N02 05OCT2007Thes

  • ceila
  • 3 Slides

Study centers The study was conducted in 25 cente...

analysis of the control groups in doubleblind trials of medicines dem

analysis of the control groups in doubleblind trials of medicines dem

  • joy
  • 22 Slides

broad variation 0 to 100 percent placebo effective...

J. Brady Scott, MSc , RRT-ACCS

J. Brady Scott, MSc , RRT-ACCS

  • pagi
  • 30 Slides

Assistant Professor . Department of Respiratory Ca...

ACE Primary Results Presentation

ACE Primary Results Presentation

  • jalin
  • 54 Slides

European Association for the Study of Diabetes. Li...

Landmark statin trials a

Landmark statin trials a

  • hadly
  • 11 Slides

cross . the . spectrum . of . risk. : . Secondary ...

The Northeast ALS Consortium

The Northeast ALS Consortium

  • unita
  • 41 Slides

Merit E. Cudkowicz, MD, MSc. Mass General Hospital...

Deciding to Participate in Research

Deciding to Participate in Research

  • jasmine
  • 19 Slides

The Pros and Cons. Natalie Diaz, MD. Pacific Neuro...

COPPS-2 Postpericardiotomy

COPPS-2 Postpericardiotomy

  • Sunshine
  • 1 Slides

syndrome: 19.4. % of the colchicine group vs. 29.4...

ODYSSEY FH I and II In FH I:

ODYSSEY FH I and II In FH I:

  • Aquamarine
  • 1 Slides

From baseline to 24 weeks, the change in . LDL-C: ...

Diabetes treatment options

Diabetes treatment options

  • StarDust
  • 46 Slides

Dr Theingi Aung. Endocrinologist. Royal Berkshire ...

Renoprotection with new

Renoprotection with new

  • DiamondsAreForever
  • 31 Slides

antidiabetic. drugs. Amouzegar. MD. Endocrine Re...

Mixedstatesinbipolarandmajordepressive

Mixedstatesinbipolarandmajordepressive

  • trinity
  • 27 Slides

Review disorders:systematicreviewandquality apprai...

CurrentPsychiatry

CurrentPsychiatry

  • victoria
  • 8 Slides

.com p SYCHIATRY SYCHIATRY Current Psychiatry Vol...

Copyright © 2024 DocSlides. All Rights Reserved